These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13071322)

  • 21. Factors affecting the action of lanatoside C on the potassium content of isolated perfused guinea pig hearts.
    HOLLAND WC; GREIG ME; DUNN CE
    Am J Physiol; 1954 Feb; 176(2):227-31. PubMed ID: 13124523
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of neriolin and lantoside in treatment of blood circulation disorders of various intensities in children].
    GOLAVSKAIA AV
    Pediatriia; 1958; 13(12):32-7. PubMed ID: 13623355
    [No Abstract]   [Full Text] [Related]  

  • 23. Study of the rate of disappearance of a digitalis glycoside, lanatoside C, from the blood of man.
    FRIEDMAN M; BINE R
    Am J Med; 1949 Mar; 6(3):387. PubMed ID: 18208196
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of lanatoside C on renal blood flow, diuresis and sodium excretion in mitral stenosis].
    BUCHT H; EK J; WERKO L; VARNAUSKAS E
    Nord Med; 1955 Aug; 54(32):1248-51. PubMed ID: 13253950
    [No Abstract]   [Full Text] [Related]  

  • 25. Employment of the embryonic duck heart for the detection of minute amounts of a digitalis glycoside (lanatoside C).
    FRIEDMAN M; BINE R
    Proc Soc Exp Biol Med; 1947 Feb; 64(2):162-5. PubMed ID: 20287364
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oxygen consumption and glycogen content of the liver and right and left ventricles of the heart of rats treated with lanatoside C of digitalis].
    MAGARO M; SENSI S; GRECO AV; MAGGI V
    Boll Soc Ital Biol Sper; 1960 Sep; 36():885-7. PubMed ID: 13765166
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of isolanid on circulatory insufficiency and vital capacity].
    GOTTSEGEN G
    Ther Hung; 1953; 10(1):23-6. PubMed ID: 13077444
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lanatoside C in hospital therapeutics].
    BOUVRAIN Y; BOURTHOUMIEUX A; BRUNET JP
    Prog Med (Paris); 1962 May; 90():302-6. PubMed ID: 13871986
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lanatoside test in diagnosis of rheumatic carditis].
    CZONICZER G; SZABO R
    Orv Hetil; 1955 May; 96(19):511-4. PubMed ID: 13245226
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lanatoside test in the detection of rheumatic carditis].
    CZONICZER G; SZABO R
    Cardiologia (Basel); 1955; 26(6):367-74. PubMed ID: 13240698
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of the administration of lanatoside C in cardiocirculatory decompensation].
    MARTELLI A
    Gazz Med Ital; 1961 Jul; 120():250-5. PubMed ID: 13767271
    [No Abstract]   [Full Text] [Related]  

  • 32. [Spectrophotometric method for the determination of cardioactive glycosides. III. Calibration curve for acetyldigitoxin, lanatoside C and strophanthoside K].
    DE SIMONE G; CINOTTI GA; MAGALINI S
    Policlinico Med; 1956 Jun; 63(3):133-6. PubMed ID: 13349505
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rapid digitalization with digilanid and cedilanid].
    BAGUENA CANDELA R; TORMO ALFONSO V
    Med Esp; 1951 Mar; 25(144):180-8. PubMed ID: 14842436
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of lanatoside C (cedilanid) in cardiac arrythmias and congestive failure.
    WEISBERG A
    N Y State J Med; 1954 Jun; 54(11):1652-8. PubMed ID: 13165977
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease].
    DE CAROLIS GD
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 115-7. PubMed ID: 13814704
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of simultaneous administration of cedilanid with glutamic acid and ATP on electrolyte metabolism in decompensated heart diseases. Part 2].
    NEUBAUER E; POR F; HONCARIV O
    Z Gesamte Inn Med; 1959 Oct; 14():966-8. PubMed ID: 14426639
    [No Abstract]   [Full Text] [Related]  

  • 37. The rate of disappearance of lanatoside C. and digitoxin from the blood of rats.
    BINE R; FRIEDMAN M
    Circulation; 1950 May; 1(5):1182-3. PubMed ID: 15411741
    [No Abstract]   [Full Text] [Related]  

  • 38. A STUDY OF THE RATE OF DISAPPEARANCE OF A DIGITALIS GLYCOSIDE (LANATOSIDE C.) FROM THE BLOOD OF MAN.
    Friedman M; Bine R
    J Clin Invest; 1949 Jan; 28(1):32-4. PubMed ID: 16695656
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of cedilanid in severe diabetes mellitus].
    HAHN A; BALZER R; PODKAMINER J; VODOPIVEE M
    Klin Med Osterr Z Wiss Prakt Med; 1951 Feb; 6(2):61-5. PubMed ID: 14825681
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intravenous cedilanid therapy of tachycardiac auricular fibrillation in circulatory insufficiency].
    PICHLER H; ZOLLNER S
    Wien Med Wochenschr; 1953 Sep; 103(35-36):663-6. PubMed ID: 13103057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.